Tuberculosis drug resistance: A global threat

Jean B. Nachega, Richard E. Chaisson

Research output: Contribution to journalArticle

Abstract

Resistance to antituberculosis drugs has been a problem since the era of chemotherapy began. After dramatic outbreaks of multidrug-resistant tuberculosis (MDR-TB) in the early 1990s, resistance became recognized as a global problem. MDR-TB now threatens the inhabitants of countries in Europe, Asia, Africa, and the Americas. An understanding of the molecular basis of drug resistance may contribute to the development of new drugs. Management of MDR-TB relies on prompt recognition and treatment with at least 3 drugs to which an isolate is susceptible.

Original languageEnglish (US)
Pages (from-to)S24-S30
JournalClinical Infectious Diseases
Volume36
Issue numberSUPPL. 1
DOIs
StatePublished - Jan 15 2003

ASJC Scopus subject areas

  • Microbiology (medical)
  • Infectious Diseases

Fingerprint Dive into the research topics of 'Tuberculosis drug resistance: A global threat'. Together they form a unique fingerprint.

  • Cite this